documents: FDA-2016-N-2880-0004

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2016-N-2880-0004 FDA FDA-2016-N-2880 Microbiology Devices; Reclassification of Cytomegalovirus Doxyribonucleic Acid Quantitative Assay Devices Intended for Transplant Patient Management, To Be Renamed Quantitative Cytomegalovirus Nucleic Acid Tests for Transplant Patient Management Proposed Rule Request for Comment 2020-09-18T04:00:00Z 2020 9 2020-09-18T04:00:00Z 2020-11-18T04:59:59Z 2020-11-18T02:01:34Z 2020-20716 0 0 090000648486493f

Links from other tables